Table 1.
COVID-19 (N = 24) | Kawasaki Disease (N = 258) | Univariate p-Value | Multivariate p-Value | Multivariate (B) | Odds Ratio | 95% CI | ||
---|---|---|---|---|---|---|---|---|
Lower | Upper | |||||||
Age (months) | 54 (16, 105) | 20 (12, 35.2) | <0.001 | 0.012 | −1.965 | 0.140 | 0.030 | 0.651 |
Male gender (%) | 12 (50%) | 152 (58.9%) | 0.397 | - | ||||
White blood cell count (×109/L) | 6.59 (3.87, 9.57) | 14.1 (10.1, 17.5) | <0.001 | 0.025 | 1.858 | 6.409 | 1.267 | 32.415 |
Neutrophil % | 47.51 (28.59, 58.8) | 61.5 (50, 73.7) | <0.001 | - | ||||
Lymphocyte % | 35.31 (20.5, 50.88) | 26.6 (17.1, 38.2) | 0.031 | - | ||||
Platelet count (×109/L) | 207 (156.75, 301.25) | 350 (268, 448) | <0.001 | 0.03 | 1.728 | 5.627 | 1.178 | 26.886 |
Hemoglobin (g/L) | 122 (113, 134.75) | 108 (100, 115) | <0.001 | - | ||||
C-reactive protein (mg/L) | 10.85 (5.82, 30) | 64.8 (34.1, 111.9) | <0.001 | - | ||||
Procalcitonin (ng/L) | 0.07 (0.048, 0.095) | 0.44 (0.16, 1.31) | <0.001 | 0.001 | 2.890 | 17.985 | 3.219 | 100.493 |
AST (U/L) | 31.5 (20.35, 40) | 36 (29, 52) | 0.015 | 0.009 | 3.150 | 23.333 | 2.166 | 251.365 |
ALT (U/L) | 18.5 (13.7, 42.25) | 21 (13, 49) | 0.453 | - |
Data were presented as medians with quartiles (Q1, Q3). AST: aspartate aminotransferase; ALT: alanine aminotransferase; multivariate (B): coefficients of variables in multivariate analysis; OR: odds ratio; CI: confidence interval. The male gender was analyzed by Pearson’s chi-square test, and others were analyzed by the Mann–Whitney U test.